Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 4: 757-766, 2020 Nov.
Article
in En
| MEDLINE
| ID: mdl-35050752
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
JCO Precis Oncol
Year:
2020
Type:
Article
Affiliation country:
Israel